TNXP · Categories · Form 4

TNXP - SEC Form 4 insider transactions

Tonix Pharmaceuticals Holding Corp. (TNXP) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for TNXP

• 38d
  SEC Form 4 filed by Director Stillwell Richard Newcomb

  4 - Tonix Pharmaceuticals Holding Corp. (0001430306) (Issuer)
• 38d
  SEC Form 4 filed by Director Olukotun Adeoye Y

  4 - Tonix Pharmaceuticals Holding Corp. (0001430306) (Issuer)
• 38d
  SEC Form 4 filed by Director Bell Margaret Smith

  4 - Tonix Pharmaceuticals Holding Corp. (0001430306) (Issuer)
• 38d
  SEC Form 4 filed by Director Hunter James Randolph Jr

  4 - Tonix Pharmaceuticals Holding Corp. (0001430306) (Issuer)
• 38d
  SEC Form 4 filed by Director Treco James

  4 - Tonix Pharmaceuticals Holding Corp. (0001430306) (Issuer)
• 38d
  SEC Form 4 filed by Director Grange David L

  4 - Tonix Pharmaceuticals Holding Corp. (0001430306) (Issuer)
• 38d
  SEC Form 4 filed by Director Bagger Richard H

  4 - Tonix Pharmaceuticals Holding Corp. (0001430306) (Issuer)
• 38d
  SEC Form 4 filed by Director Taylor Carolyn E.

  4 - Tonix Pharmaceuticals Holding Corp. (0001430306) (Issuer)
• 81d
  SEC Form 4 filed by Lederman Seth

  4 - Tonix Pharmaceuticals Holding Corp. (0001430306) (Issuer)
• 95d
  SEC Form 4 filed by Tonix Pharmaceuticals Holding Corp.

  4 - Tonix Pharmaceuticals Holding Corp. (0001430306) (Issuer)
• 115d
  SEC Form 4 filed by Chief Operating Officer Morris Jessica Edgar

  4 - Tonix Pharmaceuticals Holding Corp. (0001430306) (Issuer)
• 115d
  SEC Form 4 filed by Chief Financial Officer Saenger Bradley

  4 - Tonix Pharmaceuticals Holding Corp. (0001430306) (Issuer)
• 115d
  SEC Form 4 filed by Chief Medical Officer Sullivan Gregory M

  4 - Tonix Pharmaceuticals Holding Corp. (0001430306) (Issuer)
• 115d
  SEC Form 4 filed by Chief Technology Officer Fogarty Siobhan

  4 - Tonix Pharmaceuticals Holding Corp. (0001430306) (Issuer)
• 115d
  SEC Form 4 filed by Chief Executive Officer Lederman Seth

  4 - Tonix Pharmaceuticals Holding Corp. (0001430306) (Issuer)
• 373d
  SEC Form 4 filed by Director Hunter James Randolph Jr

  4 - Tonix Pharmaceuticals Holding Corp. (0001430306) (Issuer)
• 402d
  SEC Form 4 filed by Director Treco James

  4 - Tonix Pharmaceuticals Holding Corp. (0001430306) (Issuer)
• 402d
  SEC Form 4 filed by Director Bell Margaret Smith

  4 - Tonix Pharmaceuticals Holding Corp. (0001430306) (Issuer)
• 402d
  SEC Form 4 filed by Director Taylor Carolyn E.

  4 - Tonix Pharmaceuticals Holding Corp. (0001430306) (Issuer)
• 402d
  SEC Form 4 filed by Director Bagger Richard H

  4 - Tonix Pharmaceuticals Holding Corp. (0001430306) (Issuer)
• 402d
  SEC Form 4 filed by Director Stillwell Richard Newcomb

  4 - Tonix Pharmaceuticals Holding Corp. (0001430306) (Issuer)
• 402d
  SEC Form 4 filed by Director Olukotun Adeoye Y

  4 - Tonix Pharmaceuticals Holding Corp. (0001430306) (Issuer)
• 402d
  SEC Form 4 filed by Director Grange David L

  4 - Tonix Pharmaceuticals Holding Corp. (0001430306) (Issuer)
• 478d
  Director Bell Margaret Smith disposed of $0 worth of shares (1 units at $0.15), closing all direct ownership in the company (SEC Form 4)

  4 - Tonix Pharmaceuticals Holding Corp. (0001430306) (Issuer)
• 478d
  Director Treco James disposed of $0 worth of shares (0 units at $0.30), closing all direct ownership in the company (SEC Form 4)

  4 - Tonix Pharmaceuticals Holding Corp. (0001430306) (Issuer)
• 478d
  Director Olukotun Adeoye Y disposed of $2 worth of shares (1 units at $1.91), closing all direct ownership in the company (SEC Form 4)

  4 - Tonix Pharmaceuticals Holding Corp. (0001430306) (Issuer)
• 478d
  Director Bagger Richard H disposed of $0 worth of shares (0 units at $0.20), closing all direct ownership in the company (SEC Form 4)

  4 - Tonix Pharmaceuticals Holding Corp. (0001430306) (Issuer)
• 479d
  Chief Financial Officer Saenger Bradley disposed of 0 shares, closing all direct ownership in the company (SEC Form 4)

  4 - Tonix Pharmaceuticals Holding Corp. (0001430306) (Issuer)
• 479d
  Chief Medical Officer Sullivan Gregory M disposed of $0 worth of shares (0 units at $1.47), closing all direct ownership in the company (SEC Form 4)

  4 - Tonix Pharmaceuticals Holding Corp. (0001430306) (Issuer)
• 479d
  Chief Executive Officer Lederman Seth disposed of $18 worth of shares (6 units at $2.87), decreasing direct ownership by 51% to 5 units (SEC Form 4)

  4 - Tonix Pharmaceuticals Holding Corp. (0001430306) (Issuer)
• 479d
  Chief Operating Officer Morris Jessica Edgar disposed of 1 shares, closing all direct ownership in the company (SEC Form 4)

  4 - Tonix Pharmaceuticals Holding Corp. (0001430306) (Issuer)
• 479d
  SEC Form 4 filed by Chief Technology Officer Fogarty Siobhan

  4 - Tonix Pharmaceuticals Holding Corp. (0001430306) (Issuer)
• 758d
  SEC Form 4 filed by Treco James

  4 - Tonix Pharmaceuticals Holding Corp. (0001430306) (Issuer)
• 758d
  SEC Form 4 filed by Taylor Carolyn E.

  4 - Tonix Pharmaceuticals Holding Corp. (0001430306) (Issuer)
• 758d
  SEC Form 4 filed by Stillwell Richard Newcomb

  4 - Tonix Pharmaceuticals Holding Corp. (0001430306) (Issuer)
• 758d
  SEC Form 4 filed by Olukotun Adeoye Y

  4 - Tonix Pharmaceuticals Holding Corp. (0001430306) (Issuer)
• 758d
  SEC Form 4 filed by Grange David L

  4 - Tonix Pharmaceuticals Holding Corp. (0001430306) (Issuer)
• 758d
  SEC Form 4 filed by Bell Margaret Smith

  4 - Tonix Pharmaceuticals Holding Corp. (0001430306) (Issuer)
• 758d
  SEC Form 4 filed by Bagger Richard H

  4 - Tonix Pharmaceuticals Holding Corp. (0001430306) (Issuer)
• 837d
  SEC Form 4 filed by Lederman Seth (Amendment)

  4/A - Tonix Pharmaceuticals Holding Corp. (0001430306) (Issuer)
• 843d
  SEC Form 4 filed by Saenger Bradley

  4 - Tonix Pharmaceuticals Holding Corp. (0001430306) (Issuer)
• 843d
  SEC Form 4 filed by Lederman Seth

  4 - Tonix Pharmaceuticals Holding Corp. (0001430306) (Issuer)
• 843d
  SEC Form 4 filed by Sullivan Gregory M

  4 - Tonix Pharmaceuticals Holding Corp. (0001430306) (Issuer)
• 843d
  SEC Form 4 filed by Morris Jessica Edgar

  4 - Tonix Pharmaceuticals Holding Corp. (0001430306) (Issuer)
• 1138d
  SEC Form 4 filed by Bagger Richard H

  4 - Tonix Pharmaceuticals Holding Corp. (0001430306) (Issuer)
• 1138d
  SEC Form 4 filed by Bell Margaret Smith

  4 - Tonix Pharmaceuticals Holding Corp. (0001430306) (Issuer)
• 1138d
  SEC Form 4 filed by Grange David L

  4 - Tonix Pharmaceuticals Holding Corp. (0001430306) (Issuer)
• 1138d
  SEC Form 4 filed by Olukotun Adeoye Y

  4 - Tonix Pharmaceuticals Holding Corp. (0001430306) (Issuer)
• 1138d
  SEC Form 4 filed by Stillwell Richard Newcomb

  4 - Tonix Pharmaceuticals Holding Corp. (0001430306) (Issuer)
• 1138d
  SEC Form 4 filed by Taylor Carolyn E.

  4 - Tonix Pharmaceuticals Holding Corp. (0001430306) (Issuer)
• 1138d
  SEC Form 4 filed by Treco James

  4 - Tonix Pharmaceuticals Holding Corp. (0001430306) (Issuer)
• 1193d
  SEC Form 4 filed by Stillwell Richard Newcomb

  4 - Tonix Pharmaceuticals Holding Corp. (0001430306) (Issuer)
• 1213d
  SEC Form 4 filed by Sullivan Gregory M

  4 - Tonix Pharmaceuticals Holding Corp. (0001430306) (Issuer)
• 1213d
  SEC Form 4 filed by Saenger Bradley

  4 - Tonix Pharmaceuticals Holding Corp. (0001430306) (Issuer)
• 1213d
  SEC Form 4 filed by Morris Jessica Edgar

  4 - Tonix Pharmaceuticals Holding Corp. (0001430306) (Issuer)
• 1213d
  SEC Form 4 filed by Lederman Seth

  4 - Tonix Pharmaceuticals Holding Corp. (0001430306) (Issuer)
• 1451d
  SEC Form 4: Lederman Seth bought $34,200 worth of shares (20,000 units at $1.71)

  4 - Tonix Pharmaceuticals Holding Corp. (0001430306) (Issuer)
• 1502d
  SEC Form 4 filed by Taylor Carolyn E.

  4 - Tonix Pharmaceuticals Holding Corp. (0001430306) (Issuer)
• 1502d
  SEC Form 4 filed by Bagger Richard H

  4 - Tonix Pharmaceuticals Holding Corp. (0001430306) (Issuer)
• 1502d
  SEC Form 4 filed by Bell Margaret Smith

  4 - Tonix Pharmaceuticals Holding Corp. (0001430306) (Issuer)

Other TNXP categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends